QR Kod

Effects of GLP-1 Receptor Agonists on Bone Metabolism and Fracture Risk in Type 2 Diabetes and Obesity: Mechanisms and Clinical Evidence — A Narrative Review

Introduction and purpose: Type 2 diabetes (T2D) is associated with increased fragility fracture risk despite preserved or elevated bone mineral density (BMD) ("diabetic bone paradox"). As glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are widely used in T2D and obesity, this narrative review...

Ful tanımlama

Kaydedildi:
Asıl Yazarlar: Hubert Bojanowski, Zuzanna Marczak, Maksymilian Sito, Filip Jurkowski, Łukasz Wójcik, Natalia Gawron, Aleksandra Dobracka, Kinga Zachar, Monika Jarowicz, Jędrzej Czmyr
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Kazimierz Wielki University 2026-04-01
Seri Bilgileri:Journal of Education, Health and Sport
Konular:
Glucagon-like peptide-1 receptor agonists
Diabetes Mellitus
Obesity
Osteoporosis
Fractures, Bone
Bone Density
Online Erişim:https://apcz.umk.pl/JEHS/article/view/70093
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller